OneMedNet Corporation (ONMD) Key Metrics
ONMD valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $26.3M
- Enterprise value
- $39.1M
- P/E (TTM)
- —
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 18.1 10-yr median 84.6
- Price / book
- —
- EV / EBITDA
- 16.7
- Dividend yield
- —
- Beta
- 1.15
ONMD key metrics, 2020–2025
Fiscal year ended December 31, 2025 · U.S. dollarsONMD valuation Price multiples at each fiscal year-end price.
Price / sales−39.3%
36.1
2025 · hover or tap a bar for each year
20202025
Free cash flow yield+3.1 pts
−15.3%
2025 · hover or tap a bar for each year
20202025
ONMD returns How much profit the business earns on the capital it uses.
Return on assets+388.2 pts
−95.3%
2025 · hover or tap a bar for each year
20202025
Free cash flow margin
−553.1%
2025 · hover or tap a bar for each year
20202025
Asset turnover+50.7%
0.46
2025 · hover or tap a bar for each year
20202025
ONMD per-share figures Results divided by the shares outstanding at year-end.
Revenue per share+33.2%
$0.31
2025 · hover or tap a bar for each year
20202025
Earnings per share
−$0.63
2025 · hover or tap a bar for each year
20202025
Free cash flow per share
−$1.69
2025 · hover or tap a bar for each year
20202025
Book value per share
−$0.67
2025 · hover or tap a bar for each year
20202025
Shares outstanding+58.7%
4.5M
2025 · hover or tap a bar for each year
20202025
ONMD financial health Debt, liquidity and how easily interest is covered.
Net debt−$6.3M
−$521,000
2025 · hover or tap a bar for each year
20202025
Current ratio+130.7%
0.43
2025 · hover or tap a bar for each year
20202025
Interest coverage
-144.3
2025 · hover or tap a bar for each year
20202025
Debt / assets−88.7%
0.26
2025 · hover or tap a bar for each year
20202025
ONMD efficiency & capital use Working capital cycle and where the cash goes.
Days sales outstanding−8 days
95 days
2025 · hover or tap a bar for each year
20202025
Capex / revenue−7.0 pts
1.0%
2025 · hover or tap a bar for each year
20202025
ONMD valuation history
Fiscal year-endToday6-year median
ONMD returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
ONMD debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
ONMD cash returned to shareholders
DividendsBuybacksFree cash flow
ONMD price vs earnings per share
Share price at year-endEPS (right axis)
ONMD key metrics
2020–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| Market capitalization | $49.0M | $38.2M | $190.9M | $126.7M | $1.51B | — |
| Enterprise value | $48.5M | $43.9M | $196.0M | $152.6M | $1.52B | — |
| Price / sales | 36.1 | 59.4 | 186.9 | 109.9 | — | — |
| Price / free cash flow | — | — | 23.3 | — | — | — |
| Price / operating cash flow | — | — | 23.2 | — | — | — |
| EV / sales | 35.7 | 68.3 | 191.8 | 132.4 | — | — |
| EV / free cash flow | — | — | 24.0 | — | — | — |
| Earnings yield | −5.7% | −26.5% | −12.2% | −24.0% | −0.2% | — |
| Free cash flow yield | −15.3% | −18.4% | 4.3% | −3.8% | −0.1% | — |
| Shareholder yield (dividends + buybacks) | 0.0% | 0.5% | 15.1% | 69.9% | — | — |
| Share price at fiscal year-end | $11.00 | $13.60 | $8.10 | $104.40 | $101.00 | — |
| Per share | ||||||
| Revenue per share | $0.31 | $0.23 | $0.04 | $0.95 | $0.07 | $0.06 |
| Earnings per share | −$0.63 | −$3.61 | −$0.98 | −$25.10 | −$0.20 | −$0.19 |
| Operating cash flow per share | −$1.68 | −$2.49 | $0.35 | −$3.88 | −$0.12 | −$0.14 |
| Free cash flow per share | −$1.69 | −$2.51 | $0.35 | −$3.92 | −$0.13 | −$0.14 |
| Cash per share | $0.24 | $1.08 | $0.00 | $0.22 | $0.05 | $0.01 |
| Book value per share | −$0.67 | −$5.68 | −$0.55 | −$21.73 | −$0.38 | −$0.19 |
| Tangible book value per share | −$0.67 | −$5.68 | −$0.55 | −$21.73 | −$0.38 | −$0.19 |
| Capex per share | $0.00 | $0.02 | $0.00 | $0.05 | $0.00 | $0.00 |
| Debt per share | $0.13 | $3.12 | $0.22 | $21.63 | $0.33 | $0.17 |
| Shares outstanding | 4.5M | 2.8M | 23.6M | 1.2M | 15.0M | 15.0M |
| Change in shares outstanding | +58.7% | −88.1% | +1,843.0% | −91.9% | 0.0% | — |
| Returns & profitability | ||||||
| Return on assets (ROA) | −95.3% | −483.5% | — | — | −485.7% | −860.5% |
| Return on tangible assets | −130.2% | −271.8% | — | — | −333.0% | −860.5% |
| Free cash flow margin | −553.1% | — | 800.4% | −412.9% | −171.7% | −257.9% |
| Financial health | ||||||
| Total debt | $570,000 | $8.8M | $5.1M | $26.2M | $4.9M | $2.6M |
| Cash & short-term investments | $1.1M | $3.0M | $47,008 | $271,000 | $699,320 | $79,183 |
| Net debt | −$521,000 | $5.7M | $5.1M | $26.0M | $4.2M | $2.5M |
| Debt / assets | 0.26 | 2.35 | 11.02 | 20.36 | 5.55 | 7.92 |
| Current ratio | 0.43 | 0.19 | 0.03 | 0.01 | 0.18 | 0.19 |
| Quick ratio | 0.43 | 0.19 | 0.03 | 0.01 | 0.18 | 0.19 |
| Interest coverage | -144.3 | -65.3 | -11.2 | -19.1 | -13.9 | — |
| Working capital | −$2.7M | −$15.6M | −$12.5M | −$25.7M | −$3.9M | −$1.3M |
| Invested capital | −$3.5M | −$10.2M | −$7.8M | −$387,000 | −$1.5M | −$341,950 |
| Tangible asset value | −$3.0M | −$15.9M | −$12.9M | −$26.4M | −$5.7M | −$2.9M |
| Net current asset value | −$3.0M | −$16.1M | −$13.0M | −$27.3M | −$5.8M | −$2.9M |
| Graham net-net per share | −$0.82 | −$5.88 | −$0.56 | −$22.55 | −$0.39 | −$0.20 |
| Capital allocation | ||||||
| Share buybacks (net) | $0 | $200,000 | $28.8M | $88.5M | — | — |
| Dividends + buybacks / free cash flow | — | — | 351.6% | — | — | — |
| Capex / revenue | 1.0% | 7.9% | 4.3% | 5.0% | 2.7% | 0.0% |
| Capex / operating cash flow | — | — | 0.5% | — | — | — |
| Capex / depreciation | 0.20 | 0.89 | 1.56 | 2.32 | 2.07 | 0.00 |
| Stock-based compensation / revenue | 149.5% | 97.7% | 144.4% | 161.8% | 9.0% | 73.6% |
| R&D / revenue | 111.5% | 228.1% | 159.7% | 138.0% | 58.9% | 37.3% |
| SG&A / revenue | 562.8% | 1,221.9% | 625.3% | 1,117.0% | 165.0% | 289.1% |
| Efficiency | ||||||
| Days sales outstanding | 95.1 | 103.5 | 30.5 | 17.5 | 48.0 | 86.5 |
| Days of inventory on hand | — | — | — | 0.0 | — | — |
| Days payables outstanding | — | 2,084.8 | 851.2 | 233.5 | 174.1 | 233.4 |
| Cash conversion cycle (days) | — | -1,981.3 | -820.7 | -216.0 | -126.1 | -146.9 |
| Receivables turnover | 3.84 | 3.53 | 11.97 | 20.82 | 7.61 | 4.22 |
| Payables turnover | — | 0.18 | 0.43 | 1.56 | 2.10 | 1.56 |
| Inventory turnover | — | — | — | 3,026,000.00 | — | — |
| Asset turnover | 0.46 | 0.31 | 1.17 | 1.06 | 1.80 | 2.51 |
| Average receivables | $354,000 | $182,320 | $85,320 | $55,371 | $143,554 | $195,367 |
| Average payables | — | $5.3M | $2.7M | $967,908 | $574,967 | $391,119 |
| Average inventory | — | — | — | $0 | $0 | — |
| Intangibles / total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Computed from ONMD's annual financial statements (latest annual report filed March 30, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
ONMD valuation and financial ratios
It ended the year with $0.6 million of debt and $1.1 million in cash and short-term investments, a net cash position of $0.5 million. The share count fell 70.2% from 15.0M to 4.5M over 5 years.
See the ONMD income statement, the ONMD chart for price history, or the ONMD stock overview for the latest quote and news.
ONMD key metrics FAQ
How much debt does OneMedNet have?
OneMedNet had total debt of $0.6 million at the end of fiscal 2025 and more cash than debt.
What is OneMedNet's free cash flow yield?
OneMedNet generated -$7.5 million of free cash flow in fiscal 2025, a free cash flow yield of −15.3% on its market value at year-end ($49.0 million).
What is OneMedNet's current ratio?
OneMedNet's current ratio was 0.43 at the end of fiscal 2025: current assets were 0.43 times current liabilities.